Cargando…
Exosomes and the Prion Protein: More than One Truth
Exosomes are involved in the progression of neurodegenerative diseases. The cellular prion protein (PrP(C)) is highly expressed on exosomes. In neurodegenerative diseases, PrP(C) has at least two functions: It is the substrate for the generation of pathological prion protein (PrP(Sc)), a key player...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395619/ https://www.ncbi.nlm.nih.gov/pubmed/28469550 http://dx.doi.org/10.3389/fnins.2017.00194 |
_version_ | 1783229901946486784 |
---|---|
author | Hartmann, Alexander Muth, Christiane Dabrowski, Oliver Krasemann, Susanne Glatzel, Markus |
author_facet | Hartmann, Alexander Muth, Christiane Dabrowski, Oliver Krasemann, Susanne Glatzel, Markus |
author_sort | Hartmann, Alexander |
collection | PubMed |
description | Exosomes are involved in the progression of neurodegenerative diseases. The cellular prion protein (PrP(C)) is highly expressed on exosomes. In neurodegenerative diseases, PrP(C) has at least two functions: It is the substrate for the generation of pathological prion protein (PrP(Sc)), a key player in the pathophysiology of prion diseases. On the other hand, it binds neurotoxic amyloid-beta (Aß) oligomers, which are associated with initiation and progression of Alzheimer's disease (AD). This has direct consequences for the role of exosomal expressed PrP(C). In prion diseases, exosomal PrP leads to efficient dissemination of pathological prion protein, thus promoting spreading and transmission of the disease. In AD, exosomal PrP(C) can bind and detoxify Aß oligomers thus acting protective. In both scenarios, assessment of the state of PrP(C) on exosomes derived from blood or cerebrospinal fluid (CSF) may be useful for diagnostic workup of these diseases. This review sums up current knowledge of the role of exosomal PrP(C) on different aspects of Alzheimer's and prion disease. |
format | Online Article Text |
id | pubmed-5395619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53956192017-05-03 Exosomes and the Prion Protein: More than One Truth Hartmann, Alexander Muth, Christiane Dabrowski, Oliver Krasemann, Susanne Glatzel, Markus Front Neurosci Neuroscience Exosomes are involved in the progression of neurodegenerative diseases. The cellular prion protein (PrP(C)) is highly expressed on exosomes. In neurodegenerative diseases, PrP(C) has at least two functions: It is the substrate for the generation of pathological prion protein (PrP(Sc)), a key player in the pathophysiology of prion diseases. On the other hand, it binds neurotoxic amyloid-beta (Aß) oligomers, which are associated with initiation and progression of Alzheimer's disease (AD). This has direct consequences for the role of exosomal expressed PrP(C). In prion diseases, exosomal PrP leads to efficient dissemination of pathological prion protein, thus promoting spreading and transmission of the disease. In AD, exosomal PrP(C) can bind and detoxify Aß oligomers thus acting protective. In both scenarios, assessment of the state of PrP(C) on exosomes derived from blood or cerebrospinal fluid (CSF) may be useful for diagnostic workup of these diseases. This review sums up current knowledge of the role of exosomal PrP(C) on different aspects of Alzheimer's and prion disease. Frontiers Media S.A. 2017-04-19 /pmc/articles/PMC5395619/ /pubmed/28469550 http://dx.doi.org/10.3389/fnins.2017.00194 Text en Copyright © 2017 Hartmann, Muth, Dabrowski, Krasemann and Glatzel. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Hartmann, Alexander Muth, Christiane Dabrowski, Oliver Krasemann, Susanne Glatzel, Markus Exosomes and the Prion Protein: More than One Truth |
title | Exosomes and the Prion Protein: More than One Truth |
title_full | Exosomes and the Prion Protein: More than One Truth |
title_fullStr | Exosomes and the Prion Protein: More than One Truth |
title_full_unstemmed | Exosomes and the Prion Protein: More than One Truth |
title_short | Exosomes and the Prion Protein: More than One Truth |
title_sort | exosomes and the prion protein: more than one truth |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395619/ https://www.ncbi.nlm.nih.gov/pubmed/28469550 http://dx.doi.org/10.3389/fnins.2017.00194 |
work_keys_str_mv | AT hartmannalexander exosomesandtheprionproteinmorethanonetruth AT muthchristiane exosomesandtheprionproteinmorethanonetruth AT dabrowskioliver exosomesandtheprionproteinmorethanonetruth AT krasemannsusanne exosomesandtheprionproteinmorethanonetruth AT glatzelmarkus exosomesandtheprionproteinmorethanonetruth |